File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1093/toxsci/kfr305
- Scopus: eid_2-s2.0-84856082183
- PMID: 22048642
- WOS: WOS:000299346000023
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The role of MAPK and Nrf2 pathways in ketanserin-elicited attenuation of cigarette smoke-induced induced iL-8 production in human bronchial epithelial cells
Title | The role of MAPK and Nrf2 pathways in ketanserin-elicited attenuation of cigarette smoke-induced induced iL-8 production in human bronchial epithelial cells |
---|---|
Authors | |
Keywords | Chronic obstructive pulmonary disease Cigarette smoke Human bronchial epithelial cells Interleukin-8 Serotonin |
Issue Date | 2012 |
Publisher | Oxford University Press. The Journal's web site is located at http://toxsci.oxfordjournals.org/ |
Citation | Toxicological Sciences, 2012, v. 125 n. 2, p. 569-577 How to Cite? |
Abstract | Cigarette smoking is a major risk factor in chronic obstructive pulmonary disease (COPD) with chronic airway inflammation as a key feature. Blockade of serotonin receptor 2A (5-HTR 2A) with ketanserin has been found to improve lung function in COPD patients. Furthermore, ketanserin has been shown to possess anti-inflammatory properties in vivo. In this study, we investigated the antioxidative and anti-inflammatory properties of ketanserin and its underlying mechanism of action on cigarette smoke-induced interleukin (IL)-8 release in vitro. Primary normal human bronchial epithelial cells and human bronchial epithelial cell line (BEAS-2B) were treated with or without ketanserin prior to exposure to cigarette smoke medium (CSM). Exposure to CSM caused elevation of both mRNA and release of IL-8 with increased phosphorylation of p38 and extracellular signal-regulated kinases 1 and 2 (ERK1/2). Consistently, CSM-induced IL-8 release was blocked by SB203580, U0126, or MEK1 small interfering RNA (siRNA) but not SP600125. On the other hand, CSM caused a dose-dependent decrease in the ratio of reduced glutathione to oxidized glutathione (rGSH/GSSG) together with an increased translocation of Nrf2 to the nucleus demonstrated by Western blot analysis. Knock down of Nrf2 by siRNA completely blocked CSM-induced IL-8 release. Ketanserin suppressed CSM-induced IL-8 release by inhibiting p38, ERK1/2 MAPK, and Nrf2 signaling pathways and partially inhibited CSM-induced reduction of rGSH/GSSG ratio. Our data demonstrated the novel antioxidative and anti-inflammatory role of ketanserin via the Nrf2 signaling pathway in CSM-exposed human bronchial epithelial cells. This may open up new perspectives in the development of novel therapeutic targets in the treatment of cigarette smoke-related COPD. © The Author 2011. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/163448 |
ISSN | 2023 Impact Factor: 3.4 2023 SCImago Journal Rankings: 0.911 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lau, WKW | en_US |
dc.contributor.author | Chan, SCH | en_US |
dc.contributor.author | Law, ACK | en_US |
dc.contributor.author | Ip, MSM | en_US |
dc.contributor.author | Mak, JCW | en_US |
dc.date.accessioned | 2012-09-05T05:31:30Z | - |
dc.date.available | 2012-09-05T05:31:30Z | - |
dc.date.issued | 2012 | en_US |
dc.identifier.citation | Toxicological Sciences, 2012, v. 125 n. 2, p. 569-577 | en_US |
dc.identifier.issn | 1096-6080 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/163448 | - |
dc.description.abstract | Cigarette smoking is a major risk factor in chronic obstructive pulmonary disease (COPD) with chronic airway inflammation as a key feature. Blockade of serotonin receptor 2A (5-HTR 2A) with ketanserin has been found to improve lung function in COPD patients. Furthermore, ketanserin has been shown to possess anti-inflammatory properties in vivo. In this study, we investigated the antioxidative and anti-inflammatory properties of ketanserin and its underlying mechanism of action on cigarette smoke-induced interleukin (IL)-8 release in vitro. Primary normal human bronchial epithelial cells and human bronchial epithelial cell line (BEAS-2B) were treated with or without ketanserin prior to exposure to cigarette smoke medium (CSM). Exposure to CSM caused elevation of both mRNA and release of IL-8 with increased phosphorylation of p38 and extracellular signal-regulated kinases 1 and 2 (ERK1/2). Consistently, CSM-induced IL-8 release was blocked by SB203580, U0126, or MEK1 small interfering RNA (siRNA) but not SP600125. On the other hand, CSM caused a dose-dependent decrease in the ratio of reduced glutathione to oxidized glutathione (rGSH/GSSG) together with an increased translocation of Nrf2 to the nucleus demonstrated by Western blot analysis. Knock down of Nrf2 by siRNA completely blocked CSM-induced IL-8 release. Ketanserin suppressed CSM-induced IL-8 release by inhibiting p38, ERK1/2 MAPK, and Nrf2 signaling pathways and partially inhibited CSM-induced reduction of rGSH/GSSG ratio. Our data demonstrated the novel antioxidative and anti-inflammatory role of ketanserin via the Nrf2 signaling pathway in CSM-exposed human bronchial epithelial cells. This may open up new perspectives in the development of novel therapeutic targets in the treatment of cigarette smoke-related COPD. © The Author 2011. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. | en_US |
dc.language | eng | en_US |
dc.publisher | Oxford University Press. The Journal's web site is located at http://toxsci.oxfordjournals.org/ | en_US |
dc.relation.ispartof | Toxicological Sciences | en_US |
dc.subject | Chronic obstructive pulmonary disease | - |
dc.subject | Cigarette smoke | - |
dc.subject | Human bronchial epithelial cells | - |
dc.subject | Interleukin-8 | - |
dc.subject | Serotonin | - |
dc.title | The role of MAPK and Nrf2 pathways in ketanserin-elicited attenuation of cigarette smoke-induced induced iL-8 production in human bronchial epithelial cells | en_US |
dc.type | Article | en_US |
dc.description.nature | link_to_OA_fulltext | en_US |
dc.identifier.doi | 10.1093/toxsci/kfr305 | en_US |
dc.identifier.pmid | 22048642 | - |
dc.identifier.scopus | eid_2-s2.0-84856082183 | en_US |
dc.identifier.hkuros | 204399 | - |
dc.identifier.volume | 125 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.spage | 569 | en_US |
dc.identifier.epage | 577 | en_US |
dc.identifier.eissn | 1096-0929 | - |
dc.identifier.isi | WOS:000299346000023 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.issnl | 1096-0929 | - |